Tandem Diabetes Shares Rise on Higher Sales, New CEO

By Katherine HamiltonTandem Diabetes shares rose after it logged higher sales and named a new chief executive.The stock gained 8% to $19.50 in after-hours trading after closing down 6%.The diabetes technology company appointed Jeannette Bankes as chief executive, succeeding John Sheridan. Sheridan'…